Hypoxia-induced AZIN2 high expression may contribute to cisplatin resistance by promoting the epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC) [63]. This evidence concerns the gene AZIN2 and non-small cell lung carcinoma.